Drugs / split-virion, non-adjuvanted H1N1 vaccine
split-virion, non-adjuvanted H1N1 vaccine
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 24 trials | ||||||
| Phase 2 | NCT01494740 | Dec 2009 → Jan 2010 | influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
| Phase 2 | NCT01055990 | Oct 2009 → Apr 2010 | influenza | Shanghai Public Health Clinical Center | Unknown | No outcome recorded |
| Phase 2 | NCT00975572 | Jul → Sep 2009 | influenza | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 2 | NCT01336166 | Jul 2009 → Jul 2011 | influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00956111 | Jul → Sep 2009 | influenza | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | split-virion, non-adjuvanted H1N1 vaccine | “120 infants were assigned to receive 2 dose of 15μg split-virion, non-adjuvanted H1N1 vaccine.” NCT01494740 ↗ |
| Known as | influenza A (H1N1) 2009 monovalent, (Split-virion)inactivated vaccine | “The influenza A (H1N1) 2009 monovalent, (Split-virion)inactivated vaccine was developed by Shanghai Institute of Biological Products, and the seed virus was prepared from...” NCT01055990 ↗ |
| Modality | Vaccine | “split-virion inactivated H1N1 vaccine” NCT00975572 ↗ |
| Route | Intramuscular | “to receive intramuscular influenza H1N1 vaccine” NCT00975572 ↗ |